Key regions: Canada, United States, Australia, Brazil, Japan
The Digestives & Intestinal Remedies market in Eastern Africa has been experiencing steady growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Digestives & Intestinal Remedies market in Eastern Africa have shifted towards natural and herbal remedies. Consumers are increasingly seeking products that are derived from natural ingredients and are perceived to have fewer side effects. This preference for natural remedies is in line with global trends, as consumers become more conscious of their health and seek out products that are perceived to be safer and more sustainable.Trends in the Digestives & Intestinal Remedies market in Eastern Africa include the growing popularity of probiotics and digestive enzymes. Probiotics are live bacteria and yeasts that are beneficial for digestive health, while digestive enzymes help break down food and improve digestion. These products have gained traction in the market due to their perceived health benefits and ability to address common digestive issues such as bloating and indigestion.Local special circumstances in Eastern Africa, such as a high prevalence of gastrointestinal diseases and a lack of access to quality healthcare, have also contributed to the growth of the Digestives & Intestinal Remedies market. The region has a high burden of diseases such as diarrhea, gastritis, and peptic ulcers, which has increased the demand for remedies that can provide relief from these conditions. Additionally, limited access to healthcare facilities and trained medical professionals has led consumers to rely on over-the-counter remedies for self-medication.Underlying macroeconomic factors, such as population growth, urbanization, and rising disposable incomes, have further fueled the growth of the Digestives & Intestinal Remedies market in Eastern Africa. As the population continues to grow and more people move to urban areas, there is an increased demand for healthcare products and services. Rising disposable incomes have also made healthcare more affordable and accessible to a larger segment of the population, leading to increased spending on digestive remedies.In conclusion, the Digestives & Intestinal Remedies market in Eastern Africa is developing due to changing customer preferences towards natural remedies, emerging trends such as probiotics and digestive enzymes, local special circumstances including a high prevalence of gastrointestinal diseases and limited access to healthcare, and underlying macroeconomic factors such as population growth and rising disposable incomes. These factors are driving the growth of the market and are expected to continue shaping its development in the coming years.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
